Featured

24 January 2024

ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research

Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.

All
  • All
  • News
  • Articles
  • Events

Integrated evidence generation planning: how a HealthScience approach can improve patient care

Integrated evidence generation planning is more effective than traditional evidence generation planning. It can help pharmaceutical organizations to improve patient care and outcomes.

Continue reading

Bobby's recap: navigating the European Meeting of ISMPP as a Senior Medical Writer at Oxford PharmaGenesis

The 2024 European meeting of the International Society for Medical Publication Professionals (ISMPP), held on 23–24 January 2024, saw professionals from all areas of medical communications gather in the Novotel London West to shelter from some quintessentially British weather. I started working at Oxford PharmaGenesis only a couple of months before the world locked down…

Continue reading

Evidence generation: Oxford PharmaGenesis to collaborate on Medical Affairs education for MAPS professionals

Following an invitation from MAPS (Medical Affairs Professional Society), Oxford PharmaGenesis Communications Director Gary Male has joined the Evidence Generation Focus Area Working Group (FAWG). He will volunteer his time and expertise to help to educate the society’s membership of Medical Affairs professionals about this specialty area.

Continue reading

ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research

Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published today in the non-profit open access journal PLOS Medicine. 

Continue reading

ISMPP Europe 2024

Oxford PharmaGenesis is global, award winning and independent. Our unique HealthScience approach uses proven behaviour change techniques to maximize the impact of your communications and to ensure they resonate with the target audience. Talk to us to learn how we can help you improve collaboration, innovation, and strategy and planning.

Continue reading

Leading in 2023: our top 10 headlines and highlights

Oxford PharmaGenesis has enjoyed another great year of bringing success for clients. From innovative studies to employee milestones, to a prestigious King’s Award, here is a round-up of our top highlights and most viewed headlines of the year. Read on to find out what we have been up to in 2023, and if you are…

Continue reading